Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders

Published: Feb 02, 2007

Bangalore, India – February 2nd, 2007 – Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based integrated drug discovery services company, announced today that it has entered into a discovery collaboration with Merck Serono International S.A (Merck Serono), a global biotechnology leader. The two companies have entered into an agreement to identify small molecule drugs for the treatment of autoimmune diseases such as multiple sclerosis, and rheumatoid arthritis.

Back to news